7Z50 | pdb_00007z50

Structure of the highly diabetogenic 4.1-T cell receptor targeting a hybrid insulin peptide bound to I-Ag7.


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.65 Å
  • R-Value Free: 
    0.261 (Depositor), 0.252 (DCC) 
  • R-Value Work: 
    0.221 (Depositor) 
  • R-Value Observed: 
    0.223 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 7Z50

Ligand Structure Quality Assessment 


This is version 1.5 of the entry. See complete history

Literature

Structural plasticity in I-A g7 links autoreactivity to hybrid insulin peptides in type I diabetes.

Erausquin, E.Serra, P.Parras, D.Santamaria, P.Lopez-Sagaseta, J.

(2022) Front Immunol 13: 924311-924311

  • DOI: https://doi.org/10.3389/fimmu.2022.924311
  • Primary Citation Related Structures: 
    7QHP, 7Z50

  • PubMed Abstract: 

    We recently provided evidence for promiscuous recognition of several different hybrid insulin peptides (HIPs) by the highly diabetogenic, I-A g7 -restricted 4.1-T cell receptor (TCR). To understand the structural determinants of this phenomenon, we solved the structure of an agonistic HIP/I-A g7 complex, both in isolation as well as bound to the 4.1-TCR. We find that HIP promiscuity of the 4.1-TCR is dictated, on the one hand, by an amino acid sequence pattern that ensures I-A g7 binding and, on the other hand, by the presence of three acidic residues at positions P5, P7 and P8 that favor an optimal engagement by the 4.1-TCR's complementary determining regions. Surprisingly, comparison of the TCR-bound and unbound HIP/I-A g7 structures reveals that 4.1-TCR binding triggers several novel and unique structural motions in both the I-A g7 molecule and the peptide that are essential for docking. This observation indicates that the type 1 diabetes-associated I-A g7 molecule is structurally malleable and that this plasticity allows the recognition of multiple peptides by individual TCRs that would otherwise be unable to do so.


  • Organizational Affiliation
    • Unit of Protein Crystallography and Structural Immunology, Navarrabiomed, Navarra, Spain.

Macromolecule Content 

  • Total Structure Weight: 204.27 kDa 
  • Atom Count: 12,716 
  • Modeled Residue Count: 1,595 
  • Deposited Residue Count: 1,792 
  • Unique protein chains: 5

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
H-2 class II histocompatibility antigen, A-D alpha chain
A, C
202Mus musculusMutation(s): 1 
Gene Names: H2-Aa
UniProt
Find proteins for P04228 (Mus musculus)
Explore P04228 
Go to UniProtKB:  P04228
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP04228
Glycosylation
Glycosylation Sites: 1
Sequence Annotations
Expand
Reference Sequence
Find similar proteins by:|  3D Structure
Entity ID: 2
MoleculeChains  Sequence LengthOrganismDetailsImage
H2-Ab1 protein
B, D
230Mus musculusMutation(s): 0 
Gene Names: H2-Ab1
UniProt
Find proteins for Q31135 (Mus musculus)
Explore Q31135 
Go to UniProtKB:  Q31135
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupQ31135
Glycosylation
Glycosylation Sites: 1
Sequence Annotations
Expand
Reference Sequence
Find similar proteins by:|  3D Structure
Entity ID: 3
MoleculeChains  Sequence LengthOrganismDetailsImage
4.1 TCR beta chain
E, F
242Mus musculusMutation(s): 0 
Find similar proteins by:|  3D Structure
Entity ID: 4
MoleculeChains  Sequence LengthOrganismDetailsImage
4.1 TCR alpha chain
G, H
207Mus musculusMutation(s): 0 
Find similar proteins by:  Sequence   |   3D Structure  
Entity ID: 5
MoleculeChains  Sequence LengthOrganismDetailsImage
Hybrid insulin peptideI [auth T],
J [auth W]
15Mus musculusMutation(s): 0 

Small Molecules

Ligands 4 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
NAG

Query on NAG



Download:Ideal Coordinates CCD File
K [auth A],
M [auth B],
O [auth C],
P [auth C],
Q [auth D]
2-acetamido-2-deoxy-beta-D-glucopyranose
C8 H15 N O6
OVRNDRQMDRJTHS-FMDGEEDCSA-N
EDO

Query on EDO



Download:Ideal Coordinates CCD File
L [auth A]
N [auth B]
R [auth D]
S [auth E]
U [auth G]
L [auth A],
N [auth B],
R [auth D],
S [auth E],
U [auth G],
W [auth G]
1,2-ETHANEDIOL
C2 H6 O2
LYCAIKOWRPUZTN-UHFFFAOYSA-N
CL

Query on CL



Download:Ideal Coordinates CCD File
V [auth G]CHLORIDE ION
Cl
VEXZGXHMUGYJMC-UHFFFAOYSA-M
NA

Query on NA



Download:Ideal Coordinates CCD File
T [auth F],
X [auth H]
SODIUM ION
Na
FKNQFGJONOIPTF-UHFFFAOYSA-N

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.65 Å
  • R-Value Free:  0.261 (Depositor), 0.252 (DCC) 
  • R-Value Work:  0.221 (Depositor) 
  • R-Value Observed: 0.223 (Depositor) 
Space Group: C 1 2 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 213.615α = 90
b = 133.457β = 103.69
c = 102.56γ = 90
Software Package:
Software NamePurpose
PHENIXrefinement
XDSdata reduction
Aimlessdata scaling
MOLREPphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Spanish Ministry of Economy and CompetitivenessSpainRTI2018-093964-B-I00
Spanish Ministry of Science, Innovation, and UniversitiesSpainRYC-2017-21683
Spanish Ministry of Science, Innovation, and UniversitiesSpainPGC2018-094894-B-I00

Revision History  (Full details and data files)

  • Version 1.0: 2022-07-20
    Type: Initial release
  • Version 1.1: 2022-08-10
    Changes: Database references
  • Version 1.2: 2022-08-17
    Changes: Database references
  • Version 1.3: 2022-08-24
    Changes: Database references
  • Version 1.4: 2024-01-31
    Changes: Data collection, Refinement description
  • Version 1.5: 2024-10-16
    Changes: Structure summary